These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15311154)

  • 1. Increased soluble CD40L levels are reduced by long-term simvastatin treatment in peritoneally dialyzed patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):463-7. PubMed ID: 15311154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simvastatin and extrinsic coagulation pathway in peritoneally dialyzed patients].
    Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
    Pol Arch Med Wewn; 2002 Jun; 107(6):519-24. PubMed ID: 12371384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients.
    Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
    Am J Nephrol; 2001; 21(5):373-7. PubMed ID: 11684797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of simvastatin on aspects of thrombogenesis in CAPD patients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Perit Dial Int; 2003; 23(3):260-6. PubMed ID: 12938827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
    Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
    Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy.
    Cipollone F; Mezzetti A; Porreca E; Di Febbo C; Nutini M; Fazia M; Falco A; Cuccurullo F; Davì G
    Circulation; 2002 Jul; 106(4):399-402. PubMed ID: 12135935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
    Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy.
    Semb AG; van Wissen S; Ueland T; Smilde T; Waehre T; Tripp MD; Frøland SS; Kastelein JJ; Gullestad L; Pedersen TR; Aukrust P; Stalenhoef AF
    J Am Coll Cardiol; 2003 Jan; 41(2):275-9. PubMed ID: 12535822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients.
    Han SH; Koh KK; Quon MJ; Lee Y; Shin EK
    Atherosclerosis; 2007 Jan; 190(1):205-11. PubMed ID: 16500662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis.
    Małyszko J; Małyszko JS; Myśliwiec M
    Kidney Blood Press Res; 2004; 27(2):71-7. PubMed ID: 14691349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention.
    Lim HS; Blann AD; Lip GY
    Circulation; 2004 Jun; 109(21):2524-8. PubMed ID: 15136493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease.
    Seljeflot I; Tonstad S; Hjermann I; Arnesen H
    Atherosclerosis; 2002 May; 162(1):179-85. PubMed ID: 11947912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
    Choudhury A; Chung I; Panja N; Patel J; Lip GYH
    Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin and markers of endothelial function in patients undergoing continuous ambulatory peritoneal dialysis.
    Malyszko J; Malyszko JS; Hryszko T; Brzosko S; Mysliwiec M
    Int J Tissue React; 2002; 24(3):111-5. PubMed ID: 12635864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statins on soluble CD40 ligand in hypercholesterolemic Type 2 diabetic patients.
    Santini E; Madec S; Corretti V; Ferrannini E; Solini A
    J Endocrinol Invest; 2008 Jul; 31(7):660-5. PubMed ID: 18787388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand: a novel target in the fight against cardiovascular disease.
    Vishnevetsky D; Kiyanista VA; Gandhi PJ
    Ann Pharmacother; 2004 Sep; 38(9):1500-8. PubMed ID: 15280513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pitavastatin on monocyte chemoattractant protein-1 in hyperlipidemic patients.
    Nomura S; Shouzu A; Omoto S; Inami N; Shimazu T; Satoh D; Kajiura T; Yamada K; Urase F; Maeda Y; Iwasaka T
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):440-7. PubMed ID: 19525846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects.
    Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Maesano A; Schepis F; Zema MC; Campo GM; Squadrito F; Saitta A
    Atherosclerosis; 2001 Mar; 155(1):143-7. PubMed ID: 11223435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia.
    Barale C; Frascaroli C; Senkeev R; Cavalot F; Russo I
    Biomed Res Int; 2018; 2018():6508709. PubMed ID: 30402489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.